Technical Analysis for CNST - Constellation Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 7.28 -2.02% -0.15
CNST closed down 2.02 percent on Friday, September 20, 2019, on 6.07 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CNST trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Volume Surge Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -2.02%
Hammer Candlestick Bullish -2.02%
Lizard Bullish Bullish Day Trade Setup -2.02%
Volume Surge Other -2.02%
Doji - Bullish? Reversal -2.02%
20 DMA Support Bullish -4.08%

Older signals for CNST ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Constellation Pharmaceuticals, Inc. is a United States-based company, which discovers and develops small molecule therapeutics for the treatment of cancer, inflammatory/immunologic disorders and other diseases. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-0610, and the other program is evaluating a compound, CPI-1205. CPI-0610 is a small molecule that inhibits the binding of bromodomain and extra terminal (BET) proteins to chromatin. CPI-1205 is a small molecule that inhibits an enzyme, Enhancer of Zeste Homolog 2 (EZH2). It is in a Phase I clinical study of CPI-0610 in patients with progressive lymphoma; a Phase I clinical study of CPI-0610 in patients with acute leukemia, myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasms; a Phase I clinical study of CPI-0610 in patients with previously treated multiple myeloma, and a Phase 1 clinical study of CPI-1205 in patients with lymphoma.
Cancer Diseases Treatment Of Cancer Lymphoma Multiple Myeloma Myelodysplastic Syndrome Acute Leukemia Ezh2 Myeloproliferative Neoplasm
Is CNST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.04
52 Week Low 4.005
Average Volume 42,402
200-Day Moving Average 9.2025
50-Day Moving Average 8.2901
20-Day Moving Average 7.5245
10-Day Moving Average 7.729
Average True Range 0.7266
ADX 17.07
+DI 18.6812
-DI 23.8674
Chandelier Exit (Long, 3 ATRs ) 6.7302
Chandelier Exit (Short, 3 ATRs ) 8.6398
Upper Bollinger Band 8.1766
Lower Bollinger Band 6.8724
Percent B (%b) 0.31
BandWidth 17.332713
MACD Line -0.1518
MACD Signal Line -0.1901
MACD Histogram 0.0383
Fundamentals Value
Market Cap 12.92 Million
Num Shares 1.77 Million
EPS -49.87
Price-to-Earnings (P/E) Ratio -0.15
Price-to-Sales 0.00
Price-to-Book 0.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.09
Resistance 3 (R3) 8.09 7.81 7.96
Resistance 2 (R2) 7.81 7.61 7.82 7.91
Resistance 1 (R1) 7.55 7.48 7.41 7.55 7.86
Pivot Point 7.27 7.27 7.21 7.28 7.27
Support 1 (S1) 7.01 7.07 6.87 7.01 6.70
Support 2 (S2) 6.73 6.94 6.74 6.65
Support 3 (S3) 6.47 6.73 6.61
Support 4 (S4) 6.47